Ana Luísa Teixeira (Ana L Teixeira)

Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Biomedicines

Cancers

Molecules (Basel, Switzerland)

Antioxidants (Basel, Switzerland)

IPO-Porto

Instituto de Ciências Biomédicas Abel Salazar (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IPO-Porto Jan 02 2019

Portugal

Junior Researcher :: Molecular Oncology and Viral Pathology (IPO-Porto Research Center (CI-IPOP)

Portuguese Science Foundation Aug 01 2016 - Dec 31 2018

Portugal

Postdoctoral fellow :: Molecular Oncology and Viral Pathology (IPO-Porto Research Center (CI-IPOP)

IPO Porto Jun 01 2015 - Jul 31 2016

Portugal

Postdoctoral fellow :: Molecular Oncology and Viral Pathology (IPO-Porto Research Center (CI-IPOP)

Portuguese League Against Cancer - North Centre (LPCC) - May 31 2015

Portugal

Research fellow :: Molecular Oncology and Viral Pathology (IPO-Porto Research Center (CI-IPOP)

Portuguese Science Foundation (FCT) Jan 01 2010 - Dec 31 2013

Portugal

PhD fellow (SFRH/BD/47381/2008) :: Molecular Oncology and Viral Pathology (IPO-Porto Research Center (CI-IPOP)

Education History

Instituto de Ciências Biomédicas Abel Salazar Jan 04 2010 - Jun 27 2014

Portugal

PHD

Instituto de Ciências Biomédicas Abel Salazar - Feb 10 2009

Portugal

MSC

Publications

Mariana Morais, Francisca Dias, Patrícia Figueiredo, Inês Tavares, Carla Escudeiro, Manuel R Teixeira, Alexandra Teixeira, Johnny Lisboa, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) Uptake by Caveolae-Dependent Endocytosis is Responsible for Their Selective Effect Towards Castration Resistant Prostate Cancer. International journal of nanomedicine 19 (2024)
Beatriz Almeida, Tânia R Dias, Pedro Cruz, Mário Sousa-Pimenta, Ana Luísa Teixeira, Catarina Esteves Pereira, Bruno Costa Silva, Júlio Oliveira, Rui Medeiros, Francisca Dias
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients. Vaccines 12 (8) (2024)
Beatriz Almeida, Tânia R Dias, Ana Luísa Teixeira, Francisca Dias, Rui Medeiros
MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients? Cancers 15 (16) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Mariana Morais, Vera Machado, Patrícia Figueiredo, Francisca Dias, Rogéria Craveiro, Joana Lencart, Carlos Palmeira, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Cristina Almeida, Ana Luísa Teixeira, Francisca Dias, Mariana Morais, Rui Medeiros
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management. Biology 12 (5) (2023)
Mariana Morais, Vera Machado, Patrícia Figueiredo, Francisca Dias, Rogéria Craveiro, Joana Lencart, Carlos Palmeira, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study. Biomedicines 10 (6) (2022)
Tânia R Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira, Rui Medeiros
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 11 (15) (2022)
Mariana Morais, Vera Machado, Francisca Dias, Patrícia Figueiredo, Carlos Palmeira, Gabriela Martins, Rui Fernandes, Ana Rita Malheiro, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells. International journal of nanomedicine 17 (2022)
Cristina Almeida, Ana Luísa Teixeira, Francisca Dias, Vera Machado, Mariana Morais, Gabriela Martins, Carlos Palmeira, Maria Emília Sousa, Inês Godinho, Sílvia Batista, Bruno Costa Silva, Rui Medeiros
Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype. Biology 11 (1) (2022)
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision Medicine. Cancers 13 (24) (2021)
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives. Biomedicines 9 (12) (2021)
Mariana Morais, Vera Machado, Francisca Dias, Carlos Palmeira, Gabriela Martins, Magda Fonseca, Catarina S M Martins, Ana Luísa Teixeira, João A V Prior, Rui Medeiros
Starch-Capped AgNPs' as Potential Cytotoxic Agents against Prostate Cancer Cells. Nanomaterials (Basel, Switzerland) 11 (2) (2021)
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort. International journal of molecular sciences 23 (1) (2021)
Mariana Morais, Francisca Dias, Inês Nogueira, Anabela Leão, Nuno Gonçalves, Luís Araújo, Sara Granja, Fátima Baltazar, Ana Luísa Teixeira, Rui Medeiros
Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186. Cancers 13 (7) (2021)
Ana Luísa Teixeira, Ana Sofia Patrão, Francisca Dias, Carlos Silva, Isabel Vieira, José Fernando Silva, Marta Ferreira, António Morais, Joaquina Maurício, Rui Medeiros
AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes. Pharmacogenomics 22 (16) (2021)
Francisca Dias, Cristina Almeida, Ana Luísa Teixeira, Mariana Morais, Rui Medeiros
LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression. Biomedicines 9 (2) (2021)
Mariana Morais, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros
Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney. Cancer management and research 12 (2020)
Francisca Dias, Ana Luísa Teixeira, Inês Nogueira, Mariana Morais, Joana Maia, Cristian Bodo, Marta Ferreira, Isabel Vieira, José Silva, João Lobo, José Pedro Sequeira, Joaquina Maurício, Jorge Oliveira, Carlos Palmeira, Gabriela Martins, Klaas Kok, Bruno Costa Silva, Rui Medeiros
Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study. International journal of molecular sciences 21 (13) (2020)

Ana Luísa Teixeira.css-eqlu8i{font-size:small;padding-left:4px;} (Ana L Teixeira)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Luísa Teixeira (Ana L Teixeira)